Constipation preceding Parkinson's disease: A systematic review and meta-analysis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 87, Issue 7, 2016, Pages 710-716

  Adams Carr, Kerala L ^a   Bestwick, Jonathan P ^b   Shribman, Samuel ^c   Lees, Andrew ^d   Schrag, Anette ^d   Noyce, Alastair J ^d  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LAXATIVE;

AGE; CONSTIPATION; DEFECATION; DISEASE ASSOCIATION; DRUG USE; GENDER; HIGH RISK POPULATION; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; META ANALYSIS; ODDS RATIO; RISK; STATISTICS;

CONSTIPATION; HUMANS; ODDS RATIO; PARKINSON DISEASE; RISK; STATISTICS AS TOPIC;

EID: 84941710492     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2015-311680     Document Type: Review

References (26)

1. Kowal SL, Dall TM, Chakrabarti R, et al. The current and projected economic burden of Parkinson's disease in the United States. Mov Disord 2013; 28: 311-18
2. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-301
3. Postuma RB, Aarsland D, Barone P, et al. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 2012; 27: 617-26
4. Chen H, Zhao EJ, Zhang W, et al. Meta-Analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis. Transl Neurodegener 2015; 4: 1
5. Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-Analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 2012; 72: 893-901
6. Gao X, Chen H, Schwarzschild MA, et al. A prospective study of bowel movement frequency and risk of Parkinson's disease. Am J Epidemiol 2011; 174: 546-51
7. Plouvier AOA, Hameleers RJMG, van den Heuvel EAJ, et al. Prodromal symptoms and early detection of Parkinson's disease in general practice: a nested case-control study. Fam Pract 2014; 31: 373-8
8. Lin CH, Lin JW, Liu YC, et al. Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study. Parkinsonism Relat Disord 2014; 20: 1371-5
9. Schrag A, Horsfall L, Walters K, et al. Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. Lancet Neurol 2015; 14: 57-64
10. Pont-Sunyer C, Hotter A, Gaig C, et al. The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study). Mov Disord 2015; 30: 229-37
11. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-52
12. Rome Foundation. Guidelines-Rome III diagnostic criteria for functional gastrointestinal disorders. J Gastrointest Liver Dis 2006; 15: 307-12
13. Wells GA, Shea B, O'connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses. Canada: Department of Epidemiology and Community Medicine, University of Ottawa, 2000
14. Egger M, Smith GD, Schneider M, et al. Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34
15. Abbott RD, Ross GW, Petrovitch H, et al. Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 2007; 22: 1581-6
16. Gonera EG, Hof MV, Berger HJC, et al. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 1997; 12: 871-6
17. Savica R, Carlin JM, Grossardt BR, et al. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 2009; 73: 1752-8
18. Berg D, Marek K, Ross GW, et al. Defining at-risk populations for Parkinson's disease: lessons from ongoing studies. Mov Disord 2012; 27: 656-65
19. Braak H, de Vos RAI, Bohl J, et al. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006; 396: 67-72
20. Beach TG, Adler CH, Sue LI, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010; 119: 689-702
21. Wang CP, Sung WH, Wang CC, et al. Early recognition of pelvic floor dyssynergia and colorectal assessment in Parkinson's disease associated with bowel dysfunction. Colorectal Dis 2013; 15: e130-7
22. Pouclet H, Lebouvier T, Coron E, et al. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease. Neurogastroenterol Motil 2012; 24: e202-5
23. Lebouvier T, Neunlist M, Bruley des Varannes S, et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS ONE 2010; 5: e12728
24. Shannon KM, Keshavarzian A, Dodiya HB, et al. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord 2012; 27: 716-19
25. Hilton D, Stephens M, Kirk L, et al. Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol 2014; 127: 235-41
26. Scheperjans F, Aho V, Pereira PAB, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 2015; 30: 350-8